GSK's Eyes Benlysta Expansion With First US FDA Lupus Nephritis Approval

 
• By Jessica Merrill
  
LONDON- JUNE, 2018: The GlaxoSmithKline headquarters building in Brentford, west London. A British global pharmaceuticals company.
GSK has a new indication for Benlysta • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immunological

More from Therapeutic Category